Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Edema, Pulmonary

imatinib mesylate has been researched along with Edema, Pulmonary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Brenner, JS; Cereda, M; Delvecchio, P; Duncan, I; Hamedani, H; Humayun, S; Kadlecek, S; Makvandi, M; Martin, K; Martorano, P; Rizi, RR; Thompson, JM; Xin, Y; Yehya, N1
Aman, J; Atmowihardjo, LN; Bartelink, IH; Bet, PM; Bogaard, HJ; Bos, LDJ; Cavalla, D; Duijvelaar, E; Endeman, H; Fritchley, S; Heunks, L; Juffermans, N; Koopmans, M; McElroy, A; Purdy, K; Schippers, JR; Schultz, MJ; Swart, NEL; Tuinman, PR; van Rein, N; van Velzen, P; Vonk Noordegraaf, A1
Cai, J; Huang, J; Jiang, Q; Lin, H; Wu, L; Ye, Q1
Aman, J; Peters, MJ; van Nieuw Amerongen, GP; Vonk Noordegraaf, A; Weenink, C1
Chilakapati, DR; Chilakapati, SR; Kanala, JR; Serasanambati, M; Vissavajjhala, P1
Belknap, SM; Bennett, CL; Boyle, S; Burdon, R; Djulbegovic, B; Dorr, DA; Edwards, BJ; Georgopoulos, C; Lagman, J; McKoy, JM; Sartor, O; Tallman, MS; Talpaz, M; Weitzman, SA; West, DP1
Aman, J; Damanafshan, A; Eringa, EC; Groeneveld, AB; Huveneers, S; van Bezu, J; van Hinsbergh, VW; van Nieuw Amerongen, GP; Vogel, SM; Vonk Noordegraaf, A1
Kamath, M; Penn, MS1

Trials

1 trial(s) available for imatinib mesylate and Edema, Pulmonary

ArticleYear
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
    Critical care (London, England), 2023, 06-08, Volume: 27, Issue:1

    Topics: COVID-19; Double-Blind Method; Humans; Imatinib Mesylate; Lung; Pulmonary Edema; Respiratory Distress Syndrome

2023

Other Studies

7 other study(ies) available for imatinib mesylate and Edema, Pulmonary

ArticleYear
Imatinib alleviates lung injury and prolongs survival in ventilated rats.
    American journal of physiology. Lung cellular and molecular physiology, 2022, 06-01, Volume: 322, Issue:6

    Topics: Animals; Hydrochloric Acid; Imatinib Mesylate; Lung; Lung Injury; Pulmonary Edema; Rats; Respiration, Artificial

2022
Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study.
    BMJ open, 2023, 08-03, Volume: 13, Issue:8

    Topics: Adverse Drug Reaction Reporting Systems; Chylothorax; Dasatinib; Female; Humans; Imatinib Mesylate; Pericardial Effusion; Pharmacovigilance; Pleural Effusion; Pulmonary Edema; Pyrimidines; Retrospective Studies; United States; United States Food and Drug Administration

2023
Reversal of vascular leak with imatinib.
    American journal of respiratory and critical care medicine, 2013, Nov-01, Volume: 188, Issue:9

    Topics: Benzamides; Female; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pleural Effusion; Protein Kinase Inhibitors; Pulmonary Edema; Pyrimidines; Vascular Diseases

2013
Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib.
    Experimental lung research, 2015, Volume: 41, Issue:4

    Topics: Actins; Animals; Anti-Inflammatory Agents; Bleomycin; Bosentan; Catalase; Collagen Type I; Collagen Type II; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hydroxyproline; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Lung; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Oxidative Stress; Peroxidase; Pneumonia; Pulmonary Edema; RNA, Messenger; Sulfonamides; Superoxide Dismutase; Time Factors

2015
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jun-01, Volume: 15, Issue:11

    Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Utilization Review; Fractures, Bone; Heart Failure; Humans; Imatinib Mesylate; Infections; Neoplasms; Piperazines; Product Surveillance, Postmarketing; Professional Staff Committees; Pulmonary Edema; Pyrimidines; Time Factors

2009
Effective treatment of edema and endothelial barrier dysfunction with imatinib.
    Circulation, 2012, Dec-04, Volume: 126, Issue:23

    Topics: Animals; Benzamides; Capillary Permeability; Endothelium, Vascular; Humans; Imatinib Mesylate; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperazines; Pulmonary Edema; Pyrimidines; Skin; Treatment Outcome

2012
Novel mechanisms for maintaining endothelial barrier function in sepsis.
    Circulation, 2012, Dec-04, Volume: 126, Issue:23

    Topics: Animals; Benzamides; Capillary Permeability; Endothelium, Vascular; Humans; Imatinib Mesylate; Male; Piperazines; Pulmonary Edema; Pyrimidines

2012